Literature DB >> 19730118

Serum cytokine alteration is associated with optic neuropathy in human primary open angle glaucoma.

Ping Huang1, Yue Qi, Yong-Sheng Xu, Jiahao Liu, Duanping Liao, Samuel Shao-Min Zhang, Chun Zhang.   

Abstract

PURPOSE: The purpose of this study is to compare human serum levels of TH1 and TH2 cytokines between 2 stages of primary open-angle glaucoma (POAG) and nonglaucomatous controls.
METHODS: Thirty-two patients with primary POAG and 26 normal control subjects were enrolled into this study. The 32 patients with POAG were divided into 2 subgroups according to their mean defect (MD) with MD better than -12 dB and worse than -12 dB on the visual field. Enzyme-linked immunosorbent assay was used to assay for the levels of TH1 cytokines serum soluble interleukin-2 receptor (sIL-2R), interleukin (IL)-2, IL-12p40, IL-12p70, IL-23, tumor necrosis factor (TNF)-alpha, interferon-gamma, and TH2 cytokines IL-4, IL-6 in the peripheral serum.
RESULTS: Patients with mild glaucomatous neuropathy exhibited significant elevations in IL-4 (P<0.0001) and IL-6 (P=0.0302) compared with the controls, whereas higher concentrations of IL-4 (P<0.0001) and IL-6 (P=0.0084) were found in patients with severe glaucomatous neuropathy. The level of IL-12p70 was significantly increased in both the MD >/=12 dB (P<0.0001) and MD <12 dB (P<0.0001) groups. A significant decrease in TNF-alpha levels were observed in MD <12 dB group compared with the controls (P=0.0464), and TNF-alpha levels in MD <12 dB group were lower than MD >/=12 dB group (P=0.0328). No significant differences in serum concentrations of IL-2, sIL-2R IL-12p40, IL-23 and interferon-gamma were found between MD <12 dB group, MD >or=12 dB group, and control group.
CONCLUSIONS: Significant alterations of serum TH1 and TH2 cytokines are associated with glaucoma, suggesting the possibility that abnormal immune environments contribute to the glaucomatous neuropathy of POAG.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19730118     DOI: 10.1097/IJG.0b013e3181b4cac7

Source DB:  PubMed          Journal:  J Glaucoma        ISSN: 1057-0829            Impact factor:   2.503


  32 in total

1.  Analyzing cytokines as biomarkers to evaluate severity of glaucoma.

Authors:  Yao Tong; Ya-Li Zhou; Yan Zheng; Manas Biswal; Pei-Quan Zhao; Zhao-Yang Wang
Journal:  Int J Ophthalmol       Date:  2017-06-18       Impact factor: 1.779

2.  Peripapillary retinal nerve fiber layer and ganglion cell-inner plexiform layer thickness in adult-onset familial Mediterranean fever.

Authors:  Sait Alim; Mehmet Esen; Ayşe Kevser Demir; Selim Demir; Hüseyin Ortak; Alper Güneş; Tufan Alatli; Helin Deniz Demir
Journal:  Int Ophthalmol       Date:  2017-01-21       Impact factor: 2.031

3.  A nested case control study of plasma ICAM-1, E-selectin and TNF receptor 2 levels, and incident primary open-angle glaucoma.

Authors:  Jae H Kang; Janey L Wiggs; Louis R Pasquale
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-03-11       Impact factor: 4.799

Review 4.  The immune response in glaucoma: a perspective on the roles of oxidative stress.

Authors:  Gülgün Tezel
Journal:  Exp Eye Res       Date:  2010-08-13       Impact factor: 3.467

5.  A survey of preoperative blood tests in primary open-angle glaucoma patients versus cataract surgery patients.

Authors:  Laura P Cohen; Jessica Wong; Aliya Z Jiwani; Scott H Greenstein; Stacey C Brauner; Sherleen C Chen; Angela V Turalba; Teresa C Chen; Lucy Shen; Douglas J Rhee; Janey L Wiggs; Jae Hee Kang; Stephanie Loomis; Louis R Pasquale
Journal:  Digit J Ophthalmol       Date:  2014-06-30

Review 6.  A proteomics view of the molecular mechanisms and biomarkers of glaucomatous neurodegeneration.

Authors:  Gülgün Tezel
Journal:  Prog Retin Eye Res       Date:  2013-02-05       Impact factor: 21.198

7.  Neutrophil to Lymphocyte and Platelet to Lymphocyte Ratios in Normal Tension Glaucoma.

Authors:  Kursat Atalay; Havva Erdogan Kaldirim; Ahmet Kirgiz; Senay Asik Nacaroglu
Journal:  Med Hypothesis Discov Innov Ophthalmol       Date:  2019-10-01

Review 8.  Immune regulation toward immunomodulation for neuroprotection in glaucoma.

Authors:  Gülgün Tezel
Journal:  Curr Opin Pharmacol       Date:  2012-10-19       Impact factor: 5.547

Review 9.  Glucocorticoid therapy and ocular hypertension.

Authors:  Adnan Dibas; Thomas Yorio
Journal:  Eur J Pharmacol       Date:  2016-07-05       Impact factor: 4.432

10.  Immunomodulation as a Neuroprotective Strategy for Glaucoma Treatment.

Authors:  Mine Bariş; Gülgün Tezel
Journal:  Curr Ophthalmol Rep       Date:  2019-04-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.